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Selective killing of contaminating human fibroblasts in
epithelial cultures derived from colorectal tumours using an
anti Thy-I antibody-ricin conjugate
C. Paraskeva*, B.G. Buckle & P.E. Thorpe
Imperial Cancer Research Fund, 44 Lincoln's Inn Fields, London WC2A 3PX, UK.
We have recently developed a culture system for the
growth of epithelial cells from both benign tumours
(adenomas) and carcinomas derived from the
colorectum of Familial polyposis coli (FPC)
patients with which we intend to study
tumour progression in vitro (Paraskeva et al., 1984).
One of the problems that we encountered was that
contaminating fibroblastic cells in the cultures
tended to outgrow the epithelial cells even when the
initial fibroblastic contamination was low. Several
methods for dealing with this problem have been
reported (Gilbert & Migeon, 1975; Rheinwald &
Green, 1975; Edwards et al., 1980) but none of
them is universally applicable.
The Thy-I antigen was originally described as a
cell surface antigen on mouse thymus and brain
cells (Reif & Allan, 1964), Homologous structures
have since been detected on a number of different
cell types including rat (Stern, 1973) and human
fibroblasts (Cotmore et al., 1981) but appear to be
absent from normal colorectal epithelium and
colorectal carcinoma cells (Daar & Fabre, 1983).
This difference in the distribution of the antigen
suggested that by coupling ricin to monoclonal
anti-human Thy-I antibody we would be able to
prepare a selective cytotoxic agent for Thy-I
expressing cells and use it to rid epithelial cell
cultures of fibroblastic cells.
All tumour specimens were obtained from St
Mark's Hospital, London, UK. A detailed
description of the conditions for growing and
characterizing the epithelial cells has been reported
previously (Paraskeva et al., 1984). Briefly, tumour
specimens were washed, minced with scissors and
digested at 37°C with a solution of collagenase
(Worthington, type 4, 1.5mgml-1) and
hyaluronidase (Sigma, type 1, 0.25mgml-1) in
Dulbecco's modified Eagles Medium (DMEM).
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After overnight incubation (- 12-16h) with the
enzymes the tissue had disintegrated into glandular
epithelial tubules, clumps of cells, single cells and
cell debris. The digest was filtered through a 50
micron nylon mesh filter. The glandular epithelial
tubules and large clumps of cells were collected
from the filter, washed and put into culture. The
filtrate mostly contained cell debris and single cells
and when cultured gave rise mostly to fibroblastic
cells. Within seven days most of the glandular
epithelial tubules and clumps had attached to the
substratum and given rise to epithelial outgrowths
that were contaminated to varying degrees with
fibroblastic cells. The standard culture medium for
the epithelium was DMEM supplemented with
20% Foetal Bovine Serum, hydrocortisone
1 ugml-1, insulin 0.2unitsml-', and glutamine
2mM. Cells were cultured on 5cm petri dishes that
had previously been coated with a film of collagen
type IV (human placental collagen, Sigma) in the
presence of Swiss 3T3 feeder cells which had
previously been killed with Mitomycin C
(Paraskeva et al., 1984).
Two normal adult human skin fibroblast cell
lines BRO and REE and one foetal human
fibroblast cell line HEL 119 were kindly provided
by Dr A.M.R. Taylor, Department of Cancer
Studies, Cancer Research Campaign Laboratories,
The Medical School, Birmingham, B15 2TJ, UK.
One fibroblast cell line, designated PC/JD, was
isolated in this laboratory from a colorectal tumour
specimen derived from a polyposis coli patient.
Two epithelial cell lines, PC/AA and PC/FF were
derived from the adenomas of familial polyposis
coli patients and have been described in detail
elsewhere (Paraskeva et al., 1984).
Ricin, the toxin from the Castor bean was kindly
provided in purified form by Dr J.A. Forrester,
Institute of Cancer Research, London, U.K. The
monoclonal antibodies F-15-42-1-5 against human
Thy-I and F-8-11-13 against part of the human
leukocyte common antigen were kindly provided as
purified IgG by Dr J. Fabre, East Grinstead
Hospital, Surrey, UK. Details of the origin of the
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hybridomas and of the specificity of the antibodies
that they produce have been previously published
(McKenzie & Fabre, 1981; Dalchau & Fabre,
1981). The antibody-ricin conjugates were kindly
provided by Prof. W. Ross and Dr A. Cumber of
the Institute of Cancer Research, London, U.K.
They had been prepared using the N-
hydroxysuccinimidyl ester of chlorambucil as the
coupling agent as described by Thorpe & Ross,
1982. The component of the conjugated products
that correspond to one molecule of ricin linked to
one molecule of antibody were isolated by gel
filtration and characterised as reported previously
(Thorpe & Ross, 1982).
An isotonic (270mM) solution of galactose in
distilled water was diluted with standard growth
medium to a final galactose concentration of
lOOmM ("galactose medium"). The stock solution
of antibody-ricin conjugate contained
0.110mgricinml-l and was diluted in galactose
medium to give a final concentration of
10-3mgricinml-1. Medium was removed from the
cultures under test, the cells washed once and 2.5ml
of galactose medium containing the antibody-ricin
conjugate added and the cultures returned to the
incubator. After one hour the conjugate was
removed by washing the cells three times in
galactose medium and then three times in standard
growth medium. The purpose of the galactose in
the incubation and washing media was to block
non-specific toxicity to epithelial cells which
otherwise would have resulted from the binding of
the conjugate through its ricin moiety to galactose
residues on the surface of the cells.
Preliminary experiments using a range of
antibody-ricin conjugate concentrations established
that the conjugate at 10-3mgricinml - was
effective at killing both normal adult and foetal
fibroblasts, and fibroblasts derived from familial
polyposis coli patients, but showed no detectable
toxicity towards the epithelial cell line PC/AA. This
concentration was therefore chosen for all
subsequent work. Three normal human fibroblast
cell lines, BRO, REE, HEL 119 and one fibroblast
line, PC/JD, derived from a polyposis coli patient
were inoculated at 2.5 x 105cells per 5cm petri-dish.
Twenty-four hours later they were treated with the
antibody-ricin conjugate as described above.
Control dishes were treated with galactose medium
alone. Within four to seven days virtually all the
conjugate-treated fibroblasts had degenerated and
had detached from the culture dish, whereas the
control fibroblasts were confluent (see Figure 1 for a
typical result). The conjugate was effective on both
confluent and subconfluent fibroblastic cultures,
growing either on plastic or collagen coated petri-
dishes. Any fibroblasts that survived the first
treatment were destroyed by further treatment with
the conjugate. The conjugate showed no detectable
toxicity towards the epithelial cell lines PC/AA and
PC/FF (Figure 1; PC/FF is not shown).
Subcultures of epithelium treated with the
conjugate showed no detectable difference in
growth rate or survival from those treated with
galactose alone, again indicating that the conjugate
had not inflicted toxicity towards the epithelial
cells.
The conjugate was used routinely to rid primary
epithelial cell cultures of fibroblasts without any
detectable toxicity towards the epithelial cells.
Figure 2(a) shows a primary culture of epithelial
cells heavily contaminated with fibroblasts. The
culture was derived from a colorectal adeno-
carcinoma from a polyposis coli patient. Because
the colony shown in Figure 2(a) was so heavily
contaminated it required four treatments with the
PC/AA PC/AA PC/AA Fibroblasts Fibroblasts
Galactose Standard Antibody- Galactose Antibody-
medium medium ricin mediurm ricin
control control conjugate control conjugate
Figure 1 Cells (2.5 x IO') of the adenoma derived cell line PC/AA were inoculated onto 5cm petri-dishes. Six
days later the cells were treated with (1) galactose medium control (2) standard medium control (3) anti Thy-I
antibody-ricin conjugate. Fourteen days after the treatment cultures were fixed in Formalin and stained with
methylene blue. Cells (2.5 x 105) of the human fibroblast cell line REE were inoculated onto 5cm petri dishes.
Twenty-four hours later the cultures were treated with (4) galactose medium control (5) anti Thy-I antibody-
ricin conjugate. Seven days after the treatment cultures were fixed in formalin and stained with methylene
blue.KILLING OF FIBROBLASTS IN COLORECTAL EPITHELIAL CULTURES
Figure 2 (a) Primary culture derived from a colorectal adenocarcinoma showing an epithelial colony heavily
contaminated with fibroblasts. The arrow shows the margin of the epithelial colony (x 150). (b) Same area of
culture as in 2(a) four weeks later after 4 treatments (at approximately weekly intervals) with the anti Thy-1
antibody-ricin conjugate. In this particular culture 3T3 feeders were not used so as not to confuse them with
contaminating fibroblasts.
conjugate at approximately weekly intervals to kill
all the fibroblastic cells. Figure 2(b) shows the same
part of the epithelial colony four weeks after the
antibody-ricin conjugate treatment had started. The
two remaining fibroblastic cells in the field of view
showed no mitotic activity, and no regrowth of
fibroblasts was observed in subsequent subcultures.
Passaging the cells appeared to facilitate the killing
of fibroblasts, probably by dispersing any clumps
or very dense areas of fibroblasts or by releasing
cells hidden beneath the epithelium.
To check that the cytoxic effect of the anti-Thyl-
ricin conjugate upon the fibroblasts was mediated
through its binding to antigens on their surface, a
second conjugate was prepared from an antibody
(F-8-11-13) that reacted with neither fibroblasts nor
epithelial cells. No toxicity towards either cell type
was observed when the control conjugate was used
under the same conditions as described above for
the anti-Thyl-ricin conjugate (results not shown).
Various methods have previously been described
for the removal of contaminating fibroblasts from
epithelial cultures. EDTA has been reported to be
very effective at selectivity removing contaminating
human fibroblasts from human keratinocyte
cultures (Rheinwald & Green, 1975). However,
when tested in our system we found EDTA to
detach the epithelial cells as efflciently as the
fibroblasts (results not shown). Others have
reported the use of a fibroblast-specific monoclonal
antibody and complement to lyse fibroblasts but
found that complement was somewhat toxic to the
epithelium on its own (Edwards et al., 1980).
Another disadvantage of complement is that its
activity can vary with each batch prepared. In the
present study, an anti-Thyl-ricin conjugate was
found to provide a simple and efficient means of
selectively killing fibroblastic cells in culture. With
its use, pure epithelial cell cultures and cell lines
could routinely be established even when only a
small amount of epithelium was available to initiate
cultures, as is often the case with human tissue
specimens. An advantage of the technique was that
the epithelium could be set up untreated in primary
culture and allowed to expand in cell number
before killing fibroblastic colonies with the
conjugate. This is of particular value in the early
period of culture, during which establishment of
certain epithelial cell lines may be dependent on
mesenchymal-epithelial cell interactions.
We thank Dr W.F. Bodmer for suggesting the use of the
anti Thy-I antibody-ricin conjugate to selectively kill
contaminating fibroblasts.
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